120 related articles for article (PubMed ID: 9777988)
1. Splenic pathology in myelodysplasia: a report of 13 cases with clinical correlation.
Kraus MD; Bartlett NL; Fleming MD; Dorfman DM
Am J Surg Pathol; 1998 Oct; 22(10):1255-66. PubMed ID: 9777988
[TBL] [Abstract][Full Text] [Related]
2. Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome.
Steensma DP; Tefferi A; Li CY
Leuk Res; 2003 Sep; 27(9):775-82. PubMed ID: 12804634
[TBL] [Abstract][Full Text] [Related]
3. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
Bourgeois E; Caulier MT; Rose C; Dupriez B; Bauters F; Fenaux P
Leukemia; 2001 Jun; 15(6):950-3. PubMed ID: 11417482
[TBL] [Abstract][Full Text] [Related]
4. "Hamartoma" of the spleen (splenoma) in children.
Abramowsky C; Alvarado C; Wyly JB; Ricketts R
Pediatr Dev Pathol; 2004; 7(3):231-6. PubMed ID: 15037946
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization.
Harris NL; Demirjian Z
Am J Surg Pathol; 1991 Jan; 15(1):87-95. PubMed ID: 1845925
[TBL] [Abstract][Full Text] [Related]
6. Florid splenic γ/δ T-cell proliferation in patients with splenomegaly and cytopenias: a "high stakes" diagnostic challenge.
Zhang S; Bayerl MG
Hum Pathol; 2017 Aug; 66():216-221. PubMed ID: 28235627
[TBL] [Abstract][Full Text] [Related]
7. Assessment of immune cells and function of the residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients.
Chu HB; Zhang TG; Zhao JH; Jian FG; Xu YB; Wang T; Wang M; Tang JY; Sun HJ; Li K; Guo WJ; Zhu XJ
BMC Immunol; 2014 Oct; 15():42. PubMed ID: 25293512
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
Das R; Hayer J; Dey P; Garewal G
Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
[TBL] [Abstract][Full Text] [Related]
9. Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome.
Kouides PA; Bennett JM
Am J Hematol; 1995 Jun; 49(2):157-62. PubMed ID: 7771469
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
[TBL] [Abstract][Full Text] [Related]
11. Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates.
Kaiserling E; Horny HP; Geerts ML; Schmid U
Mod Pathol; 1994 Sep; 7(7):771-9. PubMed ID: 7824512
[TBL] [Abstract][Full Text] [Related]
12. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
[TBL] [Abstract][Full Text] [Related]
13. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
Kraemer D; Rüdiger T; Reimer P; Müller-Hermelink HK; Wilhelm M
Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
[TBL] [Abstract][Full Text] [Related]
14. The spleen as a diagnostic specimen: a review of 10 years' experience at two tertiary care institutions.
Kraus MD; Fleming MD; Vonderheide RH
Cancer; 2001 Jun; 91(11):2001-9. PubMed ID: 11391578
[TBL] [Abstract][Full Text] [Related]
15. Penicillar arterioles of red pulp in residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients: a comparative study.
Zhu X; Han W; Wang L; Chu H; Zhao J; Xu Y; Wang T; Guo W
Int J Clin Exp Pathol; 2015; 8(1):711-8. PubMed ID: 25755765
[TBL] [Abstract][Full Text] [Related]
16. Pathological splenic rupture: a rare complication of chronic myelomonocytic leukemia.
Goddard SL; Chesney AE; Reis MD; Ghorab Z; Brzozowski M; Wright FC; Wells RA
Am J Hematol; 2007 May; 82(5):405-8. PubMed ID: 17133422
[TBL] [Abstract][Full Text] [Related]
17. An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy.
Sarid N; Ahmad HN; Wotherspoon A; Dearden CE; Else M; Catovsky D
Br J Haematol; 2015 Dec; 171(5):784-7. PubMed ID: 26403440
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: retrospective analysis of 21 cases.
Chen YC; Chou JM; Letendre L; Li CY
Am J Hematol; 2005 Aug; 79(4):329-31. PubMed ID: 16044436
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.
Rigolin GM; Cuneo A; Roberti MG; Bardi A; Castoldi G
Haematologica; 1997; 82(1):25-30. PubMed ID: 9107078
[TBL] [Abstract][Full Text] [Related]
20. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases.
Neuhauser TS; Derringer GA; Thompson LD; Fanburg-Smith JC; Miettinen M; Saaristo A; Abbondanzo SL
Mod Pathol; 2000 Sep; 13(9):978-87. PubMed ID: 11007038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
